New Oral COVID-19 Antiviral Might Be Better Than Pfizer's Paxlovid With Faster Recovery, Fewer Side Effects, Data Shows
A study in China shows that a remdesivir analog, dubbed VV116, is as effective as Pfizer Inc's (NYSE: PFE) oral COVID-19 pill. Gilead Sciences Inc's (NASDAQ: GILD) Veklury (remdesivir) is approved as…
__LINK__com. Benzinga does not provide investment advice. All rights reserved.
Trending: Warren Buffett Ditched His Flip Phone for an iPhone in 2020 and Drinks 5 Cans of Coke a Day — That's What
Must Read: Brazil, Asia Take Top Honors As Best Performing Equity Markets In 2022: Here Are The Winners & Losers
Like us on Facebook to see similar stories
Please give an overall site rating: